Sharp Kinesitherapie
ActiveFrom the official registers: KBO 4 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
The annual accounts of Sharp Kinesitherapie for financial year 2025 show a net loss of 95% of the equity at the start of that year. The 2025 annual accounts show equity of €1,466 and a net result of -€30,318. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 5% of 20,678 sector peers (NACE 86, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.1% (very low).
Group and network
Connections & network
2 current directorsThe network starts from the directors of Sharp Kinesitherapie. Every other company they run is a node.